Beneski Benjamin Machinas plan to sell securities of Allogene Therapeutics, Inc. under Form 144

Beneski Benjamin Machinas filed Form 144 to notify SEC of plan to sell 4835 units of Allogene Therapeutics, Inc. securities around 2026-03-16, with aggregate market value of $11,927.50. The total outstanding units is 243777920.0. The amount planned to be sold represents 0.00% of total outstanding units;